help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 7, 2006
Endocrinology, doi:10.1210/en.2006-0866
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/12/5940    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tung, Y C L.
Right arrow Articles by Coll, A. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tung, Y C L.
Right arrow Articles by Coll, A. P
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on June 27, 2006
Accepted on August 28, 2006

A comparative study of the central effects of specific POMC-derived melanocortin peptides on food intake and body weight in Pomc null mice

Y C Loraine Tung, Sarah J Piper, Debra Yeung, Stephen O'Rahilly*, and Anthony P Coll

Department of Clinical Biochemistry, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom. CB2 2XY

* To whom correspondence should be addressed. E-mail: so104{at}medschl.cam.ac.uk.

Functional disruption of either MC3R or MC4R results in obesity, implicating both in the control of energy homeostasis. The ligands for these receptors are derived from the prohormone POMC, which is post-translationally processed to produce a set of melanocortin peptides with a range of activities at the MC3R and MC4R. The relative importance of each of these peptides ({alpha}-MSH, {gamma}3 MSH, {gamma}2 MSH, {gamma} lipotropin ({gamma}-LPH) and, in man but not in rodents, {beta}-MSH) in the maintenance of energy homeostasis is, as yet, unclear.

To investigate this further, equimolar amounts (2nmols) of each peptide were centrally administered to freely feeding, corticosterone supplemented, Pomc null (Pomc-/-) mice. Following a single dose at the onset of the dark cycle, {alpha}-MSH had the most potent anorexigenic effect, reducing food intake to 35% of sham treated animals. {beta}-MSH, {gamma}-LPH, {gamma}3-and {gamma}2- MSH all reduced food intake but to a lesser degree.

The effects of peptide administration over three days were also assessed. Only {alpha}-MSH significantly reduced body weight, affecting both fat and lean mass. Other peptides had no significant effect on body weight. Pair-feeding of sham-treated mice to those treated with {alpha}-MSH resulted in identical changes in total weight, fat and lean mass indicating that the effects of {alpha}-MSH were primarily due to reduced food intake rather than increased energy expenditure.

Although other melanocortins can reduce food intake in the short-term, only {alpha}-MSH can reduce the excess fat and lean mass found in Pomc-/- mice, mediated largely through an effect on food intake.




This article has been cited by other articles:


Home page
DiabetesHome page
V. Tolle and M. J. Low
In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice
Diabetes, January 1, 2008; 57(1): 86 - 94.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society